NPI: 1578527172 · MEMPHIS, TN 38120 · Multi-Specialty Clinic/Center · NPI assigned 04/12/2006
Authorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
| Authorized Official | DUCKETT, GREGORY (SR VP/ CLO) |
| Parent Organization | BAPTIST MEMORIAL HEALTH CARE CORP. |
| NPI Enumeration Date | 04/12/2006 |
Other providers sharing the same authorized official: DUCKETT, GREGORY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 224,243 | $9.10M |
| 2019 | 194,651 | $6.95M |
| 2020 | 150,877 | $5.18M |
| 2021 | 170,638 | $6.24M |
| 2022 | 221,646 | $8.23M |
| 2023 | 244,570 | $9.05M |
| 2024 | 156,918 | $6.70M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 87,850 | 77,679 | $14.25M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 93,687 | 87,874 | $10.89M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 40,740 | 33,455 | $8.45M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 28,094 | 27,317 | $1.99M |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 39,348 | 35,956 | $1.66M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 32,791 | 27,419 | $1.37M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2,879 | 2,425 | $1.37M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 21,369 | 20,148 | $986K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 113,607 | 54,415 | $956K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 54,546 | 49,778 | $692K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 12,159 | 11,840 | $633K |
| G0378 | Hospital observation service, per hour | 5,313 | 2,266 | $580K |
| 84484 | 38,244 | 21,736 | $574K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 14,756 | 14,337 | $512K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 21,071 | 15,177 | $507K |
| 80053 | Comprehensive metabolic panel | 101,639 | 83,022 | $503K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 80,996 | 66,622 | $488K |
| 96375 | Therapeutic injection; each additional sequential IV push | 20,777 | 16,568 | $367K |
| 71045 | Radiologic examination, chest; single view | 25,882 | 21,053 | $355K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 51,749 | 35,082 | $331K |
| 71046 | Radiologic examination, chest; 2 views | 10,274 | 9,319 | $280K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,403 | 1,984 | $274K |
| 43775 | 179 | 168 | $254K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 1,722 | 1,396 | $222K |
| 36415 | Collection of venous blood by venipuncture | 124,612 | 96,430 | $220K |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,598 | 5,175 | $180K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,320 | 2,785 | $177K |
| 87807 | 16,717 | 16,266 | $171K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2,944 | 2,679 | $171K |
| 84703 | 22,268 | 19,367 | $165K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,962 | 2,359 | $143K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 9,549 | 7,966 | $113K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 9,955 | 9,598 | $105K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,490 | 1,127 | $101K |
| 83735 | 18,172 | 13,729 | $80K | |
| 85027 | 20,590 | 15,886 | $79K | |
| 92587 | 1,892 | 977 | $77K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 5,335 | 4,792 | $76K |
| 92651 | 973 | 460 | $75K | |
| 83690 | 11,791 | 9,944 | $70K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 785 | 753 | $67K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 158 | 157 | $57K |
| 58662 | 64 | 42 | $52K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 636 | 579 | $51K |
| 81001 | 40,098 | 34,486 | $50K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 12,074 | 8,991 | $43K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 95 | 78 | $43K |
| 58571 | 43 | 28 | $41K | |
| 74246 | 616 | 592 | $33K | |
| 83880 | 2,464 | 1,761 | $32K | |
| 86900 | 1,594 | 1,073 | $30K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4,973 | 3,576 | $29K |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 2,819 | 2,132 | $25K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 599 | 220 | $24K |
| 92586 | 310 | 300 | $24K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,107 | 6,266 | $24K |
| 36821 | 46 | 36 | $21K | |
| 83605 | 2,116 | 1,703 | $18K | |
| 81025 | 4,383 | 3,989 | $18K | |
| 86850 | 1,505 | 1,004 | $16K | |
| 92585 | 308 | 107 | $15K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 29 | 25 | $15K |
| 85610 | 5,290 | 3,763 | $13K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 204 | 170 | $12K |
| 81003 | 9,268 | 8,339 | $12K | |
| 85730 | 2,027 | 1,654 | $11K | |
| 86901 | 1,629 | 1,092 | $11K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 485 | 464 | $11K |
| 0001A | 382 | 317 | $10K | |
| 0002A | 323 | 260 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 996 | 929 | $8K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 305 | 130 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 141 | 132 | $8K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 818 | 624 | $7K |
| 73130 | 523 | 426 | $6K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 13 | 12 | $6K |
| 84702 | 396 | 359 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 178 | 155 | $5K |
| 77336 | 80 | 39 | $5K | |
| 74019 | 471 | 463 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,825 | 7,834 | $4K |
| J7030 | Infusion, normal saline solution , 1000 cc | 8,012 | 6,624 | $4K |
| 76830 | Ultrasound, transvaginal | 58 | 53 | $4K |
| 73560 | 331 | 274 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 8,689 | 6,255 | $4K |
| 86140 | 555 | 536 | $3K | |
| 85379 | 271 | 241 | $3K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 13 | 13 | $2K |
| 80074 | 545 | 520 | $2K | |
| 76801 | 28 | 27 | $2K | |
| 82550 | 380 | 337 | $2K | |
| 73630 | 188 | 154 | $2K | |
| 83874 | 156 | 121 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | 618 | 584 | $1K |
| 72170 | 104 | 90 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 26 | 25 | $1K |
| 82150 | 194 | 180 | $1K | |
| 74018 | 145 | 144 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 11,341 | 9,288 | $1K |
| 72100 | 84 | 76 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 41 | 24 | $1K |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 462 | 376 | $1K |
| 80061 | Lipid panel | 568 | 532 | $985.68 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 37 | 34 | $931.70 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 37 | 34 | $931.70 |
| 72125 | Computed tomography, cervical spine; without contrast material | 25 | 14 | $849.30 |
| 93017 | 15 | 12 | $832.11 | |
| J2704 | Injection, propofol, 10 mg | 11,051 | 8,636 | $830.32 |
| 93312 | 28 | 25 | $822.70 | |
| 84480 | 551 | 525 | $788.26 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,788 | 1,310 | $768.66 |
| 87040 | 123 | 74 | $764.49 | |
| A9270 | Non-covered item or service | 8,129 | 4,702 | $728.79 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 13 | 13 | $683.18 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 118 | 111 | $642.54 |
| 0012A | 31 | 17 | $567.14 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 4,922 | 3,885 | $563.10 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 12 | 12 | $562.72 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 159 | 84 | $474.50 |
| C1769 | Guide wire | 111 | 69 | $465.82 |
| 86702 | 158 | 152 | $452.71 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 325 | 298 | $426.36 |
| 83036 | Hemoglobin; glycosylated (A1C) | 520 | 494 | $421.60 |
| 93750 | 15 | 12 | $381.55 | |
| 84436 | 546 | 520 | $364.90 | |
| 86701 | 158 | 152 | $328.86 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 2,270 | 1,798 | $318.63 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 968 | 872 | $304.31 |
| 85007 | 61 | 58 | $298.37 | |
| 97597 | 27 | 12 | $297.20 | |
| 96376 | 663 | 338 | $278.08 | |
| 96367 | 55 | 39 | $275.30 | |
| 82565 | 79 | 73 | $238.26 | |
| 0011A | 19 | 15 | $225.37 | |
| 83540 | 69 | 69 | $224.28 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,147 | 649 | $204.69 |
| 83615 | 191 | 100 | $161.13 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,695 | 2,045 | $130.83 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 108 | 52 | $111.19 |
| 93320 | 28 | 25 | $106.91 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 139 | 115 | $92.27 |
| 87300 | 29 | 27 | $81.52 | |
| G0008 | Administration of influenza virus vaccine | 24 | 18 | $72.02 |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,227 | 774 | $59.87 |
| J2060 | Injection, lorazepam, 2 mg | 21 | 15 | $58.83 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,670 | 1,956 | $58.56 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 351 | 331 | $55.44 |
| 87205 | 18 | 17 | $54.36 | |
| 87210 | 20 | 20 | $51.56 | |
| 92650 | 36 | 35 | $46.84 | |
| 93325 | 28 | 25 | $46.60 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,262 | 685 | $43.43 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,203 | 1,081 | $42.20 |
| 88307 | 124 | 116 | $37.62 | |
| 85014 | 29 | 26 | $32.03 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 7,533 | 7,233 | $19.02 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 210 | 144 | $13.00 |
| 90686 | 24 | 18 | $8.69 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 15 | 13 | $5.18 |
| J7510 | Prednisolone oral, per 5 mg | 49 | 48 | $2.52 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 114 | 107 | $0.51 |
| 80197 | 34 | 25 | $0.00 | |
| J3411 | Injection, thiamine hcl, 100 mg | 125 | 108 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 69 | 51 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 95 | 38 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 164 | 136 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 351 | 167 | $0.00 |
| 91300 | 82 | 74 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 17 | 15 | $0.00 |